Skip to content
Aussie8 – Lifestyle
Author:
Bambusa Therapeutics, Inc.
Bambusa Therapeutics Presents Positive Preliminary Multiple Ascending Dose Phase 1 Data for BBT002 at the European Academy of Allergy & Clinical Immunology (EAACI) Annual Congress 2026
June 16, 2026